Publications by authors named "Rachel Hayden"

Claim this Profile
T
The role of participatory music making in supporting people with dementia in hospital environments.
Norma Daykin, Barbara Parry, Kerry Ball, David Walters, Ann Henry, Rachel Hayden

Dementia (London)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids.
Andrew D Southam, Farhat L Khanim, Rachel E Hayden, Julia K Constantinou, Katarzyna M Koczula

Cancer Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomas.
Rachel E Hayden, Racha Kussaibati, Laura M Cronin, Guy Pratt, Claudia Roberts

Leuk Lymphoma· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
Rachel E Hayden, Guy Pratt, Claudia Roberts, Mark T Drayson, Chris M Bunce

Leuk Lymphoma· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone.
Andrew J Lilly, Farhat L Khanim, Rachel E Hayden, Quang T Luong, Mark T Drayson

Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance.
Rachel E Hayden, Guy Pratt, Mark T Drayson, Chris M Bunce

Haematologica· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML).
Jim A Murray, Farhat L Khanim, Rachel E Hayden, Charlie F Craddock, Tessa L Holyoake

Br J Haematol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a molecular beacon to track the activity of base excision repair protein OGG1 in live cells.
Leda Mirbahai, Rachael M Kershaw, Richard M Green, Rachel E Hayden, Rosalind A Meldrum

DNA Repair (Amst)· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.
Farhat L Khanim, Rachel E Hayden, Jane Birtwistle, Alessia Lodi, Stefano Tiziani

PLoS One· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects.
Nicholas J Davies, Rachel E Hayden, Paul J Simpson, Jane Birtwistle, Katarina Mayer

Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy.
Claire Pearce, Rachel E Hayden, Christopher M Bunce, Farhat L Khanim

BMC Cell Biol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis.
Jane Birtwistle, Rachel E Hayden, Farhat L Khanim, Richard M Green, Claire Pearce

Mutat Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated FOSB-expression; a potential marker of valproate sensitivity in AML.
Farhat L Khanim, Charlotte A Bradbury, Julie Arrazi, Rachel E Hayden, Adam Rye

Br J Haematol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supramolecular iron cylinder with unprecedented DNA binding is a potent cytostatic and apoptotic agent without exhibiting genotoxicity.
Anna C G Hotze, Nikolas J Hodges, Rachel E Hayden, Carlos Sanchez-Cano, Christopher Paines

Chem Biol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC.
Peter Hampson, Hema Chahal, Farhat Khanim, Rachel Hayden, Anneke Mulder

Blood· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-trans retinoic acid increases transgene expression in MSCV-transduced cells, via a mechanism that is retinoid receptor dependent but independent of cellular differentiation.
Joanne C Mountford, Elio F Vanin, Rachel E Hayden, Christopher M Bunce

Hum Gene Ther· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs.
Julian C Desmond, Joanne C Mountford, Mark T Drayson, Elizabeth A Walker, Martin Hewison, Rachel E Hayden

Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis